Continuous Renal Replacement Therapy Market: Industry Size, Current Trend, Competitive Landscape, Regional and Global Forecast To 2027
Increasing incidence of chronic diseases, such as diabetes and hypertension, fuels the risk of developing acute kidney injury. According to the National Diabetes Statistics report by CDC (Centers for Disease Control and Prevention), in 2017, 30.3 million people in the U.S. were suffering from diabetes, which accounted for around 9.4% of the total population. Approximately 23.1 million people were diagnosed with diabetes in the U.S. Lack of awareness about diabetes could lead to serious renal issues in the future. According to data published by WHO in May 2019, 1.13 billion people are estimated to be suffering from hypertension, globally. Rise in elevated blood pressure rates is likely to affect the patient population in low- and middle-income countries. Hypertension causes around 9.4 million deaths globally every year. It can affect AKI patients and may result in acute renal failure. This factor is propelling the demand for CRRT systems.
The recent COVID-19 global pandemic has also impacted the continuous renal replacement therapy market. The surge in the number of COVID cases, along with the rise in its severity rate, is likely to create a potential increase in the incidence of kidney damage. This makes AKI the next emerging healthcare concern after respiratory tract infections among patients with COVID-19. Due to the pandemic, the demand for renal replacement fluids has increased significantly worldwide. The demand for RRT among patients with COVID-19 has increased fivefold in comparison to the historical US populations (4.9% as of 2020 vs. 0.9% earlier).
Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=8988
According to UnivDatos Market Insights (UMI)’ research report “Global Continuous Renal Replacement Therapy Market Analysis, 2020”, the Global Continuous Renal Replacement Therapy market is projected to grow at a CAGR of XX% during 2021-27F. Increasing number of chronic diseases is one of the prominent reason which is driving the market of the Continuous Renal Replacement Therapy market. For Instance: In 2019, FMCNA completed acquisition of NxStage Medical, Inc. (NxStage), now part of Fresenius Renal Therapies Group And also In 2019, FMCNA manufactured 167 million dialyzers (57.6 million in the United States) and approximately 50% of the world’s dialysis machines.?
Based on the Product, the market is segmented into Disposable, Machine, Dialysates, Renal Replacement fluid. Dialysate's segment is to capture largest market share during the forecast period. The largest market share of this segment is attributed to factors such growing demand for dialysates to remove undesired solutes and restoring the electrolytes and acid-base balance in the blood along with presence of well-established players with strong offerings in dialysates & replacement fluid.?
CVVHDF to Witness Robust growth
Based on Modality, the market is segmented into SCUF, CVVH, CVVHD, CVVHDF. The CVVHDF is anticipated to witness the highest growth rate during the forecast period. The growing preference of CVVHDF modality among a nephrologist and critical care physician, and the advantages such as better clearance of medium-sized solutes as compared to hemodialysis (owing to the combination of hemofiltration with the continuous HD procedure), proper acid-base balance without additional intervention, and a significant reduction in CRRT-related phosphate depletion area likely to play strong role in supporting the growth of the segment in the coming years.
Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=8988
North America to Grab Lion’s Share, But Europe to witness Explicit Growth
Based on the Region, North America dominated the Global Continuous Renal Replacement Therapy market in 2020. North America and Europe will account for a substantial cumulative share in the global arena during the forecast period. The growth of these regions is mainly driven by the growing demand for and adoption of Continuous Renal Replacement Therapy due to rise in the incidence of AKI and rising emphasis on effective renal replacement therapy among ICU patients. The domicile of a large number of key players provides an edge to these regions and ensure their fast pace growth. ?
Asia Pacific, on the other hand, will offer promising opportunities to global participants. A surge in the geriatric population in the coming years and the subsequent increase in the prevalence of chronic diseases, the need for Continuous Renal Replacement Therapy, and implementation of favorable government initiatives and stringent regulations for Continuous Renal Replacement Therapy are also expected to propel the Continuous Renal Replacement Therapy market in the region. The increasing consumer awareness is also impacting the APAC region positively, as stated in UnivDatos Market Insights (UMI)’ research report “Global Continuous Renal Replacement Therapy Market Analysis, 2020”.??
According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the Global Continuous Renal Replacement Therapy market are Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, NIKKISO CO., LTD., B. Braun Melsungen AG, Asahi Kasei Corporation, Toray Medical Co., Ltd. , Infomed SA, Medtronic plc, Nipro Corporation. The players are focused on launching new products for gaining customers' traction and expanding their geographical reach to get a competitive edge in the industry. Some of the instances are:
§?In 2020, Medtronic plc announced the launch of the Carpediem system, the first and only pediatric and neonatal acute dialysis system designed to treat patients weighing 2.5–10 kg (5.5–22 pounds) requiring renal replacement therapy.
§?In 2019, Baxter International Inc. introduced the PrisMax CRRT system in the US
§?In 2019, Fresenius Medical Care AG & CO. KGaA announced the launch of the 4008A dialysis machine in India.?
“Global Continuous Renal Replacement Therapy Market Analysis, 2020” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for Continuous Renal Replacement Therapy providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of Go to Market Strategies and identifying the blue ocean for its offerings.???
For more informative information, please visit us – https://univdatos.com/report/continuous-renal-replacement-therapy-market/
Market Segmentation:
1.?????By Method (Disposable, Machine, Dialysates, Renal replacement fluid)
2.?????By Type (SCUF, CVVH, CVVHD, CVVHDF)
3.?????By Mode of Patient (Adult, Pediatrics, Neonates)
4.?????By Region (North America, Europe, Asia-Pacific, Rest of the World)
5.?????By Company (Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, NIKKISO CO., LTD., B. Braun Melsungen AG, Asahi Kasei Corporation, Toray Medical Co., Ltd. , Infomed SA, Medtronic plc, Nipro Corporation)
Key questions answered in the study:
1.?????What are the current and future trends of the Global Continuous Renal Replacement Therapy industry?
2.?????How the industry has been evolving in terms of end-user demand and application areas?
3.?????How the competition has been shaping across the countries followed by their comparative factorial indexing?
4.?????What are the key growth drivers and challenges for the Continuous Renal Replacement Therapy industry?
5.?????What are the customer orientation, purchase behavior, and expectations from the Continuous Renal Replacement Therapy firms across various regions??